Otis (OTIS) Q3 2024 Earnings Call Transcript

Otis reported Q3 net sales of $3.5 billion with 1.2% organic growth, driven by 7.7% Service growth, while New Equipment organic sales fell 8.2% due to a more than 20% decline in China. Management trimmed 2024 outlook to about $14.2 billion in sales and $3.85 adjusted EPS, but reiterated strong capital returns with $1.4 billion to $1.5 billion of adjusted free cash flow and $1 billion of buybacks. Service margins held at 24.8% and modernization backlog rose 12%, partly offsetting China-related headwinds.

Analysis

The key signal is not the headline guidance cut; it is the widening gap between asset-light recurring revenue and capital-intense new unit growth. Otis is effectively transitioning into a cash-generative annuity with a shrinking reliance on China new equipment, which means the market should start valuing the service and modernization flywheel more like a quality industrial compounder and less like a cyclical lift business. That mix shift also mechanically supports gross stability: as service becomes a larger share, earnings quality improves even if reported top-line growth stays pedestrian.

The second-order effect is that China weakness is now a portfolio reallocation story, not just an earnings headwind. Lower new equipment volume reduces down payments and working capital inflows this year, but it also forces cost right-sizing and accelerates the pivot toward service and mod, where returns are structurally higher. If management is right that China new equipment stabilizes near current run-rate and mod accelerates, the earnings trough may be less severe than feared, but the market will need proof that service growth in China can offset a slower install base decay.

Consensus may be underestimating how much of 2025 operating leverage is already embedded. With service margins still expanding and new equipment margins already compressed by mix, incremental improvement in Americas/EMEA and a flat China could produce better-than-modeled EPS even if unit growth remains modest. The risk is that China stimulus disappoints or merely pulls forward low-quality demand, which would delay backlog conversion and keep cash conversion below 100% for longer than expected.

The cleaner trade is not a directional long on the whole company; it is a relative-value long on the recurring-revenue annuity versus China-exposed cyclicals. Near term, the stock likely trades on whether Q4 cash flow inflects toward the implied ramp, but the bigger catalyst is January guidance for 2025: if service margin expansion remains on track and new equipment stabilizes, the market should re-rate the durability of mid-single-digit operating profit growth.

Key Decisions for Investors

• Long OTIS on a 3-6 month horizon into January guidance if the stock sells off on China headlines; risk/reward improves if the market is pricing a deeper 2025 earnings cut than service momentum justifies.
• Pair trade: long OTIS / short a China-exposed industrial or building-products basket for 1-2 quarters. Thesis: recurring service growth and buybacks de-risk OTIS relative to names where revenue is more directly tied to Chinese capex.
• If OTIS rallies sharply on China stimulus hopes, fade the move with put spreads or a partial hedge. The base case does not assume meaningful China stimulus contribution to 2025, so upside from policy headlines may be front-loaded and fade quickly.
• Look for entry on any dip toward the implied cash flow reset narrative; downside is likely capped by buybacks and dividend support, while upside comes from service margin expansion and better-than-expected working capital release in Q4.
• For options traders: consider a January post-earnings call spread rather than outright equity. The key catalyst is 2025 guidance, and the stock could re-rate if management confirms service margin expansion while new equipment stabilizes.